2010
DOI: 10.1134/s0012496610020031
|View full text |Cite
|
Sign up to set email alerts
|

Antiviral properties of structural fragments of the peptide Selank

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 1 publication
1
3
0
Order By: Relevance
“…Previously, it was shown that Selank causes a marked change in the expression of genes involved in inflammatory processes in the hippocampus and spleen of rodents (Kolomin et al, 2010 , 2011 , 2014 ). Our results have confirmed at the molecular level that the clinical effects observed after the introduction of Selank are related to its antiviral activity (Ershov et al, 2009 ; Andreeva et al, 2010 ).…”
Section: Introductionsupporting
confidence: 84%
See 1 more Smart Citation
“…Previously, it was shown that Selank causes a marked change in the expression of genes involved in inflammatory processes in the hippocampus and spleen of rodents (Kolomin et al, 2010 , 2011 , 2014 ). Our results have confirmed at the molecular level that the clinical effects observed after the introduction of Selank are related to its antiviral activity (Ershov et al, 2009 ; Andreeva et al, 2010 ).…”
Section: Introductionsupporting
confidence: 84%
“…Synthetic analogs of regulatory peptides typically contain only natural amino acids in their structure, so that they practically do not have any toxic side effects. Drugs that are developed on the basis of regulatory peptides can provide directional effects on certain human body systems and are already used for the treatment of a variety of human diseases, such as cardiovascular disease (Gusev et al, 1997 ), gastrointestinal disease (Ivanov Iu and Iasnetsov, 2000 ), viral infections (Ershov et al, 2009 ; Andreeva et al, 2010 ), and various pathologies of the nervous system (Gusev et al, 2005 ).…”
Section: Introductionmentioning
confidence: 99%
“…The study of the antiviral properties of the structural fragments of the Selank peptide allowed the selection of Gly-Pro as the minimum amino acid sequence (pharmacophore) that had a pronounced antiviral effect. Among the fragments of Selank studied, the tetrapeptide Arg-Pro-Gly-Pro exhibited the highest antiviral activity against the human influenza A/Aichi2/68 virus (H 3 N 2 ), the human influenza B/Ohio01/05 virus, the avian influenza virus (H 5 N 1 ), the herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), the cytomegalovirus (CMV), and the murine encephalomyocarditis virus (EMCV) [182].…”
Section: Immunomodulatory Effectmentioning
confidence: 99%
“…Three Selank fragments were selected for analysis: the natural regulatory peptide tuftsin, with a macrophageactivating effect, the Arg-Pro-Gly-Pro peptide, which exhibited the largest antiviral activity, and the dipeptide Gly-Pro, which is the smallest structural Selank unit that retains antiviral activity [182]. Selank and its fragments caused changes in the expression of 35 genes involved in inflammation (chemokines, cytokines, and their receptors) in the mouse spleen at 6 h and 24 h after a single intraperitoneal injection of the drug.…”
Section: Effect Of Selank On the Transcriptomementioning
confidence: 99%